TransMedics (USA) chooses Mirandola for its European Hub
The investment by the U.S. group, active in organ transplant technologies, strengthens the regional biomedical district and foresees the hiring of around 50-100 highly qualified new employees.
The investment by the U.S. group, active in organ transplant technologies, strengthens the regional biomedical district and foresees the hiring of around 50-100 highly qualified new employees.
The event took place in Washington D.C. on October 25 and was part of a wider national mission aimed at strengthening the relationships among clusters, ecosystems and investors.
In Bologna the new high training center on skills for the industry of the future to be completed by this summer. The center will be built next to the Philip Morris Manufacturing & Technology Bologna production plant in Crespellano (Bologna) and will respect the most advanced environmental sustainability standards.
Medtronic, US multinational leader in medical technologies, invested heavily in two companies of its group that are part of the regional biomedical district of Mirandola (Modena): Bellco and Mallinckrodt.
3/11/2021 - Two important foreign investors in Emilia-Romagna are finding here the right conditions to grow and expand.